|
KMID : 0338420130280010081
|
|
The Korean Journal of Internal Medicine
2013 Volume.28 No. 1 p.81 ~ p.88
|
|
|
Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions
|
|
Seok Han-Nah
Lee Eun-Young
Choe Eun-Yeong
Yang Woo-in
Kim Joo-Young
Shin Dong-Yeob
Cho Ho-Jin
Kim Tae-Sung
Yun Mi-Jin
Lee Jung-Doo
Lee Eun-Jig
Lim Sung-Kil
Rhee Yu-Mie
|
|
|
Abstract
|
|
|
Background/Aims: Although magnetic resonance imaging (MRI) is a good visual modality for the evaluation of pituitary lesions, it has limited value in the diagnosis of mixed nodules and some cystic lesions. We evaluated the usefulness of 18F-fluorodeoxyglucose positron emission tomography (FDG PET) for patients with pituitary lesions.
Methods: 18F-FDG PET and MRI were performed simultaneously in 32 consecutive patients with pituitary lesions. The relationships between FDG uptake patterns in PET and MRI findings were analyzed.
Results: Of 24 patients with piuitary adenomas, 19 (79.2%) showed increased uptake of 18F-FDG in the pituitary gland on PET scans. All patients with pituitary macroadenomas showed increased 18F-FDG uptake on PET scans. Meanwhile, only five (50%) of the 10 patients with pituitary microadenomas showed positive PET scans. Interestingly, of two patients with no abnormal MRI findings, one showed increased 18F-FDG uptake on PET. For positive 18F-FDG uptake, maximum standardized uptake values (SUVmax) > 2.4 had 94.7% sensitivity and 100% specificity. In addition, SUVmax increased in proportion to the size of pituitary adenomas. Most cystic lesions did not show 18F-FDG uptake on PET scans.
Conclusions: About 80% of pituitary adenomas showed positivity on PET scans, and SUVmax was related to the size of the adenomas. PET may be used as an ancillary tool for detection and differentiation of pituitary lesions.
|
|
|
KEYWORD
|
|
|
Pituitary, Positron-emission tomography, Magnetic resonance imaging
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|